On Tuesday, October 24, 2023,  AxoSim announced the completion of its acquisition of the microBrain™-associated assets of Vyant Bio’s StemoniX subsidiary—news of the acquisition generated excitement among the scientific, pharmaceutical, and business communities.

From The Times-Picayune/The New Orleans Advocate to Fierce Biotech, local and national media featured news of the acquisition with quotes from AxoSim Co-Founder and CEO Lowry Curley, PhD and investor Mrs. Gayle Benson. See some of the highlights in the news roundup below.  We are thankful to all the reporters and publications who shared our story and helped us receive great coverage of our acquisition. 

(Picture Above L-R: New Orleans BioInnovation Center Director Kris Khalil, Owner of the New Orleans Saints Mrs. Gayle Benson and AxoSim Co-Founder and CEO Lowry Curley PhD.)